Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma

BackgroundRenal cell carcinoma (RCC) is a disease of genomic alterations, of which the complete panorama helps in facilitating molecular-guided therapy. Germline mutation profiles and associated somatic and clinical characteristics remains unexplored in Chinese RCC patients.MethodsWe retrospectively...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wen Kong, Tongtong Yang, Xiaodong Wen, Zhongyi Mu, Cheng Zhao, Sujun Han, Jing Tian, Xinhao Zhang, Tao Zhou, Yanrui Zhang, Feng Lou, Shanbo Cao, Huina Wang, Jin Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/2c8e8e86d9754e66a2e676592b8c377c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c8e8e86d9754e66a2e676592b8c377c
record_format dspace
spelling oai:doaj.org-article:2c8e8e86d9754e66a2e676592b8c377c2021-12-02T10:54:01ZGermline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma2234-943X10.3389/fonc.2021.737547https://doaj.org/article/2c8e8e86d9754e66a2e676592b8c377c2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.737547/fullhttps://doaj.org/toc/2234-943XBackgroundRenal cell carcinoma (RCC) is a disease of genomic alterations, of which the complete panorama helps in facilitating molecular-guided therapy. Germline mutation profiles and associated somatic and clinical characteristics remains unexplored in Chinese RCC patients.MethodsWe retrospectively profiled the germline and somatic mutations of 322 unselected RCC patients using a panel consisting of 808 cancer-related genes. We categorized patients into three groups based on germline mutation status and compared the somatic mutation spectrum among different groups.ResultsApproximately one out of ten (9.9%) RCC patients were identified to carry pathogenic/likely pathogenic (P/LP) germline variants (PGVs), of which 3.7% were variants in syndromic RCC-associated genes and 6.2% were other cancer-predisposition genes. The most common PGV was found in VHL (2.2%), followed by FH, TSC2, ATM, BRCA1, NBN, and BLM (0.6% each). Young patients (≤46 years) were more likely to harbor PGVs. Variants in syndromic RCC-associated genes were predominant identified in young patients, while variants in other cancer-predisposition genes were found in patients >46 years more frequently. Furthermore, 39.3% (11/28) of patients carrying PGVs were detected to have somatic “second hit” events. Germline and somatic sequencing, including microsatellite instability (MSI) status analysis, provided potentially actionable therapeutic targets in 17.1% of patients in the whole cohort.ConclusionsOur results revealed that approximately 10% of RCC patients carried clinically significant germline mutations. Current guidelines recommendation for genetic testing seemed not sensitive enough to identify patients with hereditary RCC susceptibility. It is rational to promote genetic testing in RCC population.Wen KongTongtong YangXiaodong WenZhongyi MuCheng ZhaoSujun HanJing TianXinhao ZhangTao ZhouYanrui ZhangFeng LouShanbo CaoHuina WangJin ZhangFrontiers Media S.A.articlerenal cell carcinomagermline mutationsChinese populationpathogenic variationsecond hit eventsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic renal cell carcinoma
germline mutations
Chinese population
pathogenic variation
second hit events
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle renal cell carcinoma
germline mutations
Chinese population
pathogenic variation
second hit events
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Wen Kong
Tongtong Yang
Xiaodong Wen
Zhongyi Mu
Cheng Zhao
Sujun Han
Jing Tian
Xinhao Zhang
Tao Zhou
Yanrui Zhang
Feng Lou
Shanbo Cao
Huina Wang
Jin Zhang
Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
description BackgroundRenal cell carcinoma (RCC) is a disease of genomic alterations, of which the complete panorama helps in facilitating molecular-guided therapy. Germline mutation profiles and associated somatic and clinical characteristics remains unexplored in Chinese RCC patients.MethodsWe retrospectively profiled the germline and somatic mutations of 322 unselected RCC patients using a panel consisting of 808 cancer-related genes. We categorized patients into three groups based on germline mutation status and compared the somatic mutation spectrum among different groups.ResultsApproximately one out of ten (9.9%) RCC patients were identified to carry pathogenic/likely pathogenic (P/LP) germline variants (PGVs), of which 3.7% were variants in syndromic RCC-associated genes and 6.2% were other cancer-predisposition genes. The most common PGV was found in VHL (2.2%), followed by FH, TSC2, ATM, BRCA1, NBN, and BLM (0.6% each). Young patients (≤46 years) were more likely to harbor PGVs. Variants in syndromic RCC-associated genes were predominant identified in young patients, while variants in other cancer-predisposition genes were found in patients >46 years more frequently. Furthermore, 39.3% (11/28) of patients carrying PGVs were detected to have somatic “second hit” events. Germline and somatic sequencing, including microsatellite instability (MSI) status analysis, provided potentially actionable therapeutic targets in 17.1% of patients in the whole cohort.ConclusionsOur results revealed that approximately 10% of RCC patients carried clinically significant germline mutations. Current guidelines recommendation for genetic testing seemed not sensitive enough to identify patients with hereditary RCC susceptibility. It is rational to promote genetic testing in RCC population.
format article
author Wen Kong
Tongtong Yang
Xiaodong Wen
Zhongyi Mu
Cheng Zhao
Sujun Han
Jing Tian
Xinhao Zhang
Tao Zhou
Yanrui Zhang
Feng Lou
Shanbo Cao
Huina Wang
Jin Zhang
author_facet Wen Kong
Tongtong Yang
Xiaodong Wen
Zhongyi Mu
Cheng Zhao
Sujun Han
Jing Tian
Xinhao Zhang
Tao Zhou
Yanrui Zhang
Feng Lou
Shanbo Cao
Huina Wang
Jin Zhang
author_sort Wen Kong
title Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
title_short Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
title_full Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
title_fullStr Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
title_full_unstemmed Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma
title_sort germline mutation landscape and associated clinical characteristics in chinese patients with renal cell carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/2c8e8e86d9754e66a2e676592b8c377c
work_keys_str_mv AT wenkong germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT tongtongyang germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT xiaodongwen germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT zhongyimu germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT chengzhao germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT sujunhan germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT jingtian germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT xinhaozhang germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT taozhou germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT yanruizhang germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT fenglou germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT shanbocao germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT huinawang germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
AT jinzhang germlinemutationlandscapeandassociatedclinicalcharacteristicsinchinesepatientswithrenalcellcarcinoma
_version_ 1718396460547964928